Hyun-Hwan Jeong

Hyun-Hwan Jeong

Auto-generated profile, based on publicly available information

Hyun-Hwan Jeong

Baylor College of Medicine

Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 June 2018 in Cell Reports
Verified
Journal Article
Open access
CGCaiwei Guo
Caiwei Guo
HJHyun-Hwan Jeong
Hyun-Hwan Jeong
YHYi-Chen Hsieh
Yi-Chen Hsieh
HKHans-Ulrich Klein
Hans-Ulrich Klein
DBDavid A. Bennett
David A. Bennett
JSJoshua M. Shulman
Joshua M. Shulman
Aging and neurodegenerative disease are characterized by genomic instability in neurons, including aberrant activation and mobilization of transposable elements (TEs). Integrating studies of human postmortem brain tissue and Drosophila melanogaster models, we investigate TE activation in association with Tau pathology in Alzheimer's disease (AD). Leveraging RNA sequencing from 636 human brains, we discover differential expression for several retrotransposons in association with neurofibrillary tangle burden and highlight evidence for global TE transcriptional activation among the long interspersed nuclear element 1 and endogenous retrovirus clades. In addition, we detect Tau-associated, active chromatin signatures at multiple HERV-Fc1 genomic loci. To determine whether Tau is sufficient to induce TE activation, we profile retrotransposons in Drosophila expressing human wild-type or mutant Tau throughout the brain. We discover heterogeneous response profiles, including both age- and genotype-dependent activation of TE expression by Tau. Our results implicate TE activation and associated genomic instability in Tau-mediated AD mechanisms.

19 April 2021 in Cell
Verified
Journal Article
Closed access
WZWeijie Zhang
Weijie Zhang
IBIgor L. Bado
Igor L. Bado
JHJingyuan Hu
Jingyuan Hu
YWYing-Wooi Wan
Ying-Wooi Wan
LWLing Wu
Ling Wu
XZXiang H.-F. Zhang
Xiang H.-F. Zhang

14 July 2017 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
PDF file
SRSoung-Hun Roh
Soung-Hun Roh
CHCorey F. Hryc
Corey F. Hryc
HJHyun-Hwan Jeong
Hyun-Hwan Jeong
XFXue Fei
Xue Fei
JJJoanita Jakana
Joanita Jakana
WCWah Chiu
Wah Chiu
Significance: Using cryo-EM and expanding on focused classification allowed for the bacterial chaperone, GroEL, to be structurally resolved at atomic detail one particle at a time. This approach differs from generating the traditional structural ensemble average of presumably identical particle images. Three dominant subunit conformations were identified, and their spatial distributions were found to be different in each individual GroEL oligomer. This strategy demonstrates the application of cryo-EM to characterize the biophysical properties of structural dynamics of individual molecular machines one at a time.

24 September 2018 in Journal of Neuroscience
Verified
Journal Article
Open access
PDF file
MRMaxime W.C. Rousseaux
Maxime W.C. Rousseaux
GVGabriel E. Vázquez-Vélez
Gabriel E. Vázquez-Vélez
IAIsmael Al-Ramahi
Ismael Al-Ramahi
HJHyun-Hwan Jeong
Hyun-Hwan Jeong
ABAleksandar Bajić
Aleksandar Bajić
HZHuda Y. Zoghbi
Huda Y. Zoghbi
Accumulation of α-Synuclein (α-Syn) causes Parkinson's disease (PD) as well as other synucleopathies. α-Syn is the major component of Lewy bodies and Lewy neurites, the proteinaceous aggregates that are a hallmark of sporadic PD. In familial forms of PD, mutations or copy number variations inSNCA(the α-Syn gene) result in a net increase of its protein levels. Furthermore, common risk variants tied to PD are associated with small increases ofwild-typeα-Syn levels. These findings are further bolstered by animal studies which show that overexpression of α-Syn is sufficient to cause PD-like features. Thus, increased α-Syn levels are intrinsically tied to PD pathogenesis and underscore the importance of identifying the factors that regulate its levels. In this study, we establish a pooled RNAi screening approach and validation pipeline to probe the druggable genome for modifiers of α-Syn levels and identify 60 promising targets. Using a cross-species, tiered validation approach, we validate six strong candidates that modulate α-Syn levels and toxicity in cell lines,Drosophila, human neurons, and mouse brain of both sexes. More broadly, this genetic strategy and validation pipeline can be applied for the identification of therapeutic targets for disorders driven by dosage-sensitive proteins.SIGNIFICANCE STATEMENTWe present a research strategy for the systematic identification and validation of genes modulating the levels of α-Synuclein, a protein involved in Parkinson's disease. A cell-based screen of the druggable genome (>7,500 genes that are potential therapeutic targets) yielded many modulators of α-Synuclein that were subsequently confirmed and validated inDrosophila, human neurons, and mouse brain. This approach has broad applicability to the multitude of neurological diseases that are caused by mutations in genes whose dosage is critical for brain function.

23 April 2019 in Genome Research
Verified
Journal Article
Open access
PDF file
HJHyun-Hwan Jeong
Hyun-Hwan Jeong
SKSeon Young Kim
Seon Young Kim
MRMaxime W.C. Rousseaux
Maxime W.C. Rousseaux
HZHuda Y. Zoghbi
Huda Y. Zoghbi
ZLZhandong Liu
Zhandong Liu
The simplicity and cost-effectiveness of CRISPR technology have made high-throughput pooled screening approaches accessible to virtually any laboratory. Analyzing the large sequencing data derived from these studies, however, still demands considerable bioinformatics expertise. Various methods have been developed to lessen this requirement, but there are still three tasks for accurate CRISPR screen analysis that involve bioinformatic know-how, if not prowess: designing a proper statistical hypothesis test for robust target identification, developing an accurate mapping algorithm to quantify sgRNA levels, and minimizing the parameters that need to be fine-tuned. To make CRISPR screen analysis more reliable as well as more readily accessible, we have developed a new algorithm, called CRISPRBetaBinomial or CB2. Based on the beta-binomial distribution, which is better suited to sgRNA data, CB2 outperforms the eight most commonly used methods (HiTSelect, MAGeCK, PBNPA, PinAPL-Py, RIGER, RSA, ScreenBEAM, and sgRSEA) in both accurately quantifying sgRNAs and identifying target genes, with greater sensitivity and a much lower false discovery rate. It also accommodates staggered sgRNA sequences. In conjunction with CRISPRcloud, CB2 brings CRISPR screen analysis within reach for a wider community of researchers.

27 February 2015 in Bioinformatics
Verified
Journal Article
Open access
PDF file
KSKyung-Ah Sohn
Kyung-Ah Sohn
JHJoshua W. K. Ho
Joshua W. K. Ho
DDDjordje Djordjevic
Djordje Djordjevic
HJHyun-Hwan Jeong
Hyun-Hwan Jeong
PPPeter Park
Peter Park
JKJu Han Kim
Ju Han Kim
Motivation: Genome-wide mapping of chromatin states is essential for defining regulatory elements and inferring their activities in eukaryotic genomes. A number of hidden Markov model (HMM)-based methods have been developed to infer chromatin state maps from genome-wide histone modification data for an individual genome. To perform a principled comparison of evolutionarily distant epigenomes, we must consider species-specific biases such as differences in genome size, strength of signal enrichment and co-occurrence patterns of histone modifications. Results: Here, we present a new Bayesian non-parametric method called hierarchically linked infinite HMM (hiHMM) to jointly infer chromatin state maps in multiple genomes (different species, cell types and developmental stages) using genome-wide histone modification data. This flexible framework provides a new way to learn a consistent definition of chromatin states across multiple genomes, thus facilitating a direct comparison among them. We demonstrate the utility of this method using synthetic data as well as multiple modENCODE ChIP-seq datasets. Conclusion: The hierarchical and Bayesian non-parametric formulation in our approach is an important extension to the current set of methodologies for comparative chromatin landscape analysis. Availability and implementation: Source codes are available at https://github.com/kasohn/hiHMM. Chromatin data are available at http://encode-x.med.harvard.edu/data_sets/chromatin/. Contact:peter_park@harvard.edu or juhan@snu.ac.kr Supplementary information: Supplementary data are available at Bioinformatics online.